D.C. Insider Says Scientists Must Court Politicians

Former congressman Walgren, now a lobbyist, advises his clients to befriend lawmakers before advancing their own cause WASHINGTON--Scientists who feel frustrated because they can't get Congress to consider their remedies for what ails science can take a tip from a former legislator who is already sympathetic to their cause: Leave your data at home and start thinking instead about becoming friends with the congressional member whose ear you're trying to gain. Doug Walgren was such a frien

Written byJeffrey Mervis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Former congressman Walgren, now a lobbyist, advises his clients to befriend lawmakers before advancing their own cause
WASHINGTON--Scientists who feel frustrated because they can't get Congress to consider their remedies for what ails science can take a tip from a former legislator who is already sympathetic to their cause: Leave your data at home and start thinking instead about becoming friends with the congressional member whose ear you're trying to gain.

Doug Walgren was such a friend. He was a staunch advocate of science during a career in which he served as chairman of the House science committee's research and technology subcommittee, which over- sees the National Science Foundation.

He also served as chairman of the subcommittee on consumer protection and competitiveness within the Energy and Commerce Committee, which oversees the National Institutes of Health. The seven-term incumbent Democrat was upset last November in a close race in his suburban ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies